Diagnostic Performance of PET or PET/CT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours according to Published Meta-Analyses.
Journal
Contrast media & molecular imaging
ISSN: 1555-4317
Titre abrégé: Contrast Media Mol Imaging
Pays: England
ID NLM: 101286760
Informations de publication
Date de publication:
2020
2020
Historique:
received:
26
03
2020
accepted:
09
04
2020
entrez:
15
5
2020
pubmed:
15
5
2020
medline:
1
7
2021
Statut:
epublish
Résumé
Several meta-analyses have reported data about the diagnostic performance of positron emission tomography or positron emission tomography/computed tomography (PET or PET/CT) with different radiotracers in patients with suspicious lung cancer (LC) or pleural tumours (PT). This review article aims at providing an overview on the recent evidence-based data in this setting. A comprehensive literature search of meta-analyses published in PubMed/MEDLINE and Cochrane Library database from January 2010 through March 2020 about the diagnostic performance of PET or PET/CT with different radiotracers in patients with suspicious LC or PT was performed. This combination of keywords was used: (A) "PET" OR "positron emission tomography" AND (B) "lung" OR "pulmonary" OR "pleur We have summarized the diagnostic performance of PET or PET/CT with fluorine-18 fluorodeoxyglucose ( Evidence-based data about the diagnostic performance of PET/CT with different radiotracers for suspicious LC or PT are increasing, with good diagnostic performance of
Identifiants
pubmed: 32405280
doi: 10.1155/2020/5282698
pmc: PMC7196984
doi:
Substances chimiques
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
5282698Informations de copyright
Copyright © 2020 Filippo Lococo et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Acad Radiol. 2012 Feb;19(2):153-8
pubmed: 22104289
Chest. 2015 Feb;147(2):502-512
pubmed: 25188411
Nucl Med Commun. 2017 Jan;38(1):67-75
pubmed: 27741214
J Cancer Res Ther. 2016 Dec;12(Supplement):C304-C308
pubmed: 28230044
J Thorac Dis. 2018 Apr;10(Suppl 7):S779-S789
pubmed: 29780624
Nucl Med Commun. 2012 Oct;33(10):1011-8
pubmed: 22825038
JAMA. 2014 Sep 24;312(12):1227-36
pubmed: 25247519
Radiology. 2019 Feb;290(2):525-534
pubmed: 30480492
Eur J Radiol. 2015 Jul;84(7):1371-7
pubmed: 25864441
Asian Pac J Cancer Prev. 2015;16(6):2215-7
pubmed: 25824740
Radiol Bras. 2016 Mar-Apr;49(2):104-11
pubmed: 27141133
Clin Transl Oncol. 2014 Sep;16(9):770-5
pubmed: 24647843
J Thorac Dis. 2019 May;11(5):2082-2098
pubmed: 31285902
Acta Radiol. 2013 Sep;54(7):770-7
pubmed: 23528566
Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1438-9; author reply 1439
pubmed: 12898206
Ann Thorac Surg. 2014 Oct;98(4):1214-22
pubmed: 25087933
Biomed Res Int. 2014;2014:852681
pubmed: 24963486
Medicine (Baltimore). 2018 Mar;97(12):e0130
pubmed: 29561412
Nucl Med Commun. 2019 May;40(5):508-516
pubmed: 30875336
J Thorac Dis. 2014 Mar;6(3):237-48
pubmed: 24624288
Cancer Imaging. 2013 Dec 14;13(4):458-65
pubmed: 24334433
Acad Radiol. 2014 Jan;21(1):11-20
pubmed: 24331260
Clin Lung Cancer. 2012 May;13(3):161-70
pubmed: 22133290
Mol Clin Oncol. 2015 Jan;3(1):101-108
pubmed: 25469278